Literature DB >> 28927175

Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands.

Floris S van den Brink1, Martin J Swaans1, Mark G Hoogendijk1, Arash Alipour1, Johannes C Kelder1, Wybren Jaarsma1, Frank D Eefting1, Bjorn Groenmeijer2,3, A Jon Funke Kupper4, Jurrien M Ten Berg1.   

Abstract

Aims: After the introduction of the European Society of Cardiology (ESC) guidelines on prevention, diagnosis, and treatment of infective endocarditis (IE) in 2009, prophylaxis for patients at risk became less strict. We hypothesize that there will be a rise in IE after the introduction of the guideline update. Methods and
Results: We performed a nationwide retrospective trend study using segmented regression analysis of the interrupted time series. The patient data were obtained via the national healthcare insurance database, which collects all the diagnoses nationwide. We compared the data before and after the introduction of the 2009 ESC guideline. Between 2005 and 2011, a total of 5213 patients were hospitalized with IE in the Netherlands. During this period, there was a significant increase in IE from 30.2 new cases per 1 000 000 in 2005 to 62.9 cases per 1 000 000 in 2011 (P < 0.001). In 2009, the incidence of IE increased significantly above the projected historical trend (rate ratio: 1.327, 95% CI: 1.205-1.462; P < 0.001). This coincides with the introduction of the 2009 ESC guideline. After the introduction of the ESC guideline, the streptococci-positive cultures increased significantly in the following years 2010-11 from 31.1 to 53.2% (P = 0.0031).
Conclusion: This observational study shows that there has been a steady increase in the IE incidence between 2005 and 2011. After the introduction of the 2009 ESC guidelines, the incidence increased more than expected from previous historical trends. Furthermore, there was a significant increase in streptococci-related IE cases. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Endocarditis; Guidelines; Prevention

Mesh:

Year:  2017        PMID: 28927175     DOI: 10.1093/ehjqcco/qcw039

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


  17 in total

1.  Aortic valve repair in endocarditis: scope and results.

Authors:  Silvia Solari; Saadallah Tamer; Gaby Aphram; Stefano Mastrobuoni; Emiliano Navarra; Philippe Noirhomme; Alain Poncelet; Parla Astarci; Jean Rubay; Gébrine El Khoury; Laurent De Kerchove
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-07-19

2.  A Contemporary Population-Based Profile of Infective Endocarditis Using the Expanded Rochester Epidemiology Project.

Authors:  Larry M Baddour; Aylin Shafiyi; Brian D Lahr; Nandan S Anavekar; James M Steckelberg; Walter R Wilson; M Rizwan Sohail; Daniel C DeSimone
Journal:  Mayo Clin Proc       Date:  2021-03-05       Impact factor: 11.104

3.  Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population.

Authors:  Nicola Serra; Claudia Colomba; Paola Di Carlo; Gabriele Palermo; Teresa Fasciana; Anna Giammanco; Giuseppina Novo; Teresa Rea; Maria Michela Marino; Vincenzo Argano; Consolato Sergi
Journal:  Cureus       Date:  2020-05-28

4.  Trends in occurrence and 30-day mortality of infective endocarditis in adults: population-based registry study in Finland.

Authors:  Elina Ahtela; Jarmo Oksi; Pekka Porela; Tommi Ekström; Paivi Rautava; Ville Kytö
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

5.  Native aortic valve endocarditis with Morganella morganii in a patient with multiple myeloma and valvular amyloidosis: a case report.

Authors:  Renée van Bentum; Judith Nieken; Esther de Waal; Mels Hoogendoorn
Journal:  BMC Infect Dis       Date:  2019-11-10       Impact factor: 3.090

6.  International guideline changes and the incidence of infective endocarditis: a systematic review.

Authors:  Omeair Khan; Ahmed Mohamed Abdel Shafi; Adam Timmis
Journal:  Open Heart       Date:  2016-08-25

7.  Infective endocarditis in the Netherlands: current epidemiological profile and mortality : An analysis based on partial ESC EORP collected data.

Authors:  S El Kadi; D M F van den Buijs; T Meijers; M D Gilbers; S C A M Bekkers; J P van Melle; R K Riezebos; W L Blok; W Tanis; A R Wahadat; J W Roos-Hesselink; T I G van der Spoel; S A J Chamuleau; O Kamp
Journal:  Neth Heart J       Date:  2020-10       Impact factor: 2.854

8.  DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci.

Authors:  Carmen Hidalgo-Tenorio; David Vinuesa; Antonio Plata; Pilar Martin Dávila; Simona Iftimie; Sergio Sequera; Belén Loeches; Luis Eduardo Lopez-Cortés; Mari Carmen Fariñas; Concepción Fernández-Roldan; Rosario Javier-Martinez; Patricia Muñoz; Maria Del Mar Arenas-Miras; Francisco Javier Martínez-Marcos; Jose Maria Miró; Carmen Herrero; Elena Bereciartua; Samantha E De Jesus; Juan Pasquau
Journal:  Ann Clin Microbiol Antimicrob       Date:  2019-10-19       Impact factor: 3.944

9.  Occurrence of fatal infective endocarditis: a population-based study in Finland.

Authors:  Elina Ahtela; Jarmo Oksi; Jussi Sipilä; Päivi Rautava; Ville Kytö
Journal:  BMC Infect Dis       Date:  2019-11-21       Impact factor: 3.090

10.  Incidence and outcome of prosthetic valve endocarditis after transcatheter aortic valve replacement in the Netherlands.

Authors:  J Brouwer; F S van den Brink; V J Nijenhuis; T N Vossenberg; R Delewi; M S van Mourik; P den Heijer; W Tanis; P C Kievit; W Holvoet; R S Hermanides; J M Ten Berg
Journal:  Neth Heart J       Date:  2020-10       Impact factor: 2.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.